Application | Comment | Organism |
---|---|---|
medicine | CD26 is an appropriate molecular target for renal cell carcinoma therapy. Anti-CD26 mAb treatment leads to loss of tumorigenicity. The potent antitumor effect of anti-CD26 mAb may be used in the future as novel therapeutic approaches against various CD26-positive malignancies, including renal cell carcinoma | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |